The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the toxicity of a variety of environmental chemicals, such as polycyclic aromatic hydrocarbons (PAHs) and dioxins. We hypothesized that polymorphisms of AHR may result in significant differences in sensitivity to toxic effects of PAHs or dioxins and contribute to susceptibility to male infertility. To address this possibility, we conducted a study including 580 idiopathic infertile subjects and 580 fertile controls to assess associations between the male infertility risk and six tagging single nucleotide polymorphisms of AHR gene. Additionally, correlations between AHR polymorphisms and sperm concentration, levels of DNA fragmentation, and benzo(a)pyrene diolepoxide (BPDE)-DNA adducts in sperm were determined in 420 patients. Genotypes were determined using the ABI OpenArray platform. Sperm DNA fragmentation was evaluated by terminal deoxyribonucleotidyl transferase (TdT)-mediated dUDP nick-end labelling (TUNEL) assay, and sperm BPDE-DNA adducts were measured by immunofluorescent assay using flow cytometry. We found that the G variant of rs2158041 was associated with significantly increased risk of male infertility (adjusted odds ratio 1.53, 95% confidence interval 1.21-1.93; p 5 6.0 3 10
There is evidence that semen quality has declined in the last three decades, and the incidence of male infertility has increased steadily in many countries (Andersson et al., 2008; Swan et al., 2000) . Although possible reasons remain unclear, reports indicated that environmental exposure to toxic pollutants may play an important role in these trends (Hauser and Sokol, 2008; Perry, 2008; Sadeu et al., 2010) .
Polycyclic aromatic hydrocarbons (PAHs) and dioxins are widespread environmental contaminants, produced from the incomplete combustion of organic materials or the manufacture of chlorinated hydrocarbons. Both experimental and epidemiologic studies have reported the adverse impacts of PAHs and dioxins on male reproductive health (Arima et al., 2009; Foster et al., 2010; Han et al., 2011; Inyang et al., 2003; Mocarelli et al., 2008; Simanainen et al., 2004; Verhofstad et al., 2011; Xia et al., 2009a,b) .
It is believed that toxic effects of PAHs and dioxins are primarily mediated by an aryl hydrocarbon receptor (AHR), which is a ligand-activated transcriptional factor that plays a potential role in various human diseases (Rowlands and Gustafsson, 1997) . After binding PAHs or dioxins, AHR translocates into the nucleus to interact with xenobiotic responsive elements then resulting in the upregulation of phase I and II enzymes, such as cytochrome P450 and glutathione S-transferases, which are also involved in the metabolism of PAHs and dioxins (Eaton and Bammler, 1999; Xue and Warshawsky, 2005) . Based on studies with AHR-deficient mice, which are resistant to PAHs and dioxins toxicity, it is understood that the AHR is responsible for these toxicity (Buchanan et al., 2000; Fernandez-Salguero et al., 1996; Matsumoto et al., 2007; Peters et al., 1999; Shimizu et al., 2000; Thurmond et al., 1999) .
As for the male reproductive system, the testicular tissue expresses abundant amounts of messenger RNA (mRNA) of AHR and its nuclear translocator mRNA, and the presence of AHR in sperm provides a mechanism by which environmental PAHs, dioxins, and polyhalogenated biphenyls could directly influence sperm function (Khorram et al., 2004) . It has been demonstrated that testicular functions, especially spermatogenesis and sperm motility, are specifically reduced by exposure to PAHs through the activation of AHR (Izawa et al., 2007; Kee et al., 2010) . Besides, resveratrol, a natural competitive inhibitor of the AHR, could protect the sperm from DNA damage and apoptosis caused by benzo[a]pyrene (BaP), suggesting that the AHR is involved in the toxic effects of BaP (Revel et al., 2001) .
Apart from mediating toxicity of environmental chemicals, the AHR has also been implicated in several physiological functions independent of exogenous chemical exposure. A recent study demonstrates that the seminal vesicle regresses in aged AHR-deficient mice, and this regression is likely caused by a decrease in testosterone production (Baba et al., 2008) .
Based upon the possible contribution of AHR to the pathogenesis of male infertility, we hypothesized that changes of AHR protein activity by genetic variation may modulate the adverse effects of PAHs and confer individual susceptibility to male infertility. To test this hypothesis, we selected six tagging single nucleotide polymorphisms (tagSNPs) in the AHR gene from the data for Chinese in the HapMap (http://www.hapmap.org/) to evaluate the association between common genetic variants in AHR and risk of male infertility in a Chinese population. Moreover, we also evaluated their potential impacts on sperm concentration as well as DNA fragmentation and BPDE-DNA adducts formation in human sperm.
MATERIALS AND METHODS
Subjects and sample collection. The study was approved by the Ethics Review Board of the Nanjing Medical University. All the studies involving human subjects were conducted in full compliance with government policies and the Declaration of Helsinki. A total of 1657 infertile patients, diagnosed with unexplained male factor infertility, were drawn from the Center of Clinical Reproductive Medicine between April 2005 and March 2009 (NJMU Infertile Study). All patients underwent at least two semen analyses, and those with a history of orchitis, obstruction of the vas deferens, chromosomal abnormalities, or microdeletions of the azoospermia factor region on the Y chromosome were excluded (Lu et al., 2009; Wu et al., 2007; Zhang et al., 2007) . In the final analysis, 580 idiopathic infertility patients aged 24-to 42-year old were included.
A total of 580 healthy men aged 25-to 40-year old were sampled as the controls, at the same hospitals the patients were recruited. All these subjects had normal sperm concentration, motility and morphology, and had fathered one or more healthy children. The semen analysis for sperm concentration, motility, and morphology was performed following the World Health Organization (WHO) criteria (WHO, 1999) .
SNP selection, tagSNPs identification, and genotyping. The tagSNPs were selected by using genotype data obtained from unrelated Han Chinese individuals from Beijing in the HapMap project (HapMap Data Rel 24/Phase II Nov08, on NCBI B36 assembly, dbSNP b126). We extensively examined the AHR gene, including 2000 bp of the flanking regions both upstream and downstream of the gene, using the pairwise option of the Haploview 4.0 software (Barrett et al., 2005) . The tagSNPs were selected on the basis of pairwise linkage disequilibrium (LD) with the r 2 threshold of 0.8 and minor allele frequency ! 0.05 to capture all the common SNPs.
Genotyping was performed using the OpenArray platform (Applied Biosystems, Foster City, CA), which employed a chip-based TaqMan genotyping technology. According to the manufacturer's standard protocols, genotyping was conducted and genotype calls were made by OpenArray SNP Genotyping Analysis Software V.1.0.3. For quality control, the genotyping was done without knowledge of case/control status of subjects, and a random 5% of cases and controls were genotyped twice by different individuals, and the reproducibility was 100%. To confirm the genotyping results, selected PCRamplified DNA samples (n ¼ 2, for each genotype) were examined by DNA sequencing and the results were also consistent.
Semen quality analysis. Semen samples were obtained and analyzed in duplicate according to WHO guidelines (WHO, 1999).
DNA fragmentation analysis. A detailed protocol of the terminal deoxyribonucleotidyl transferase (TdT)-mediated dUDP nick-end labelling (TUNEL) assay for human sperm has been described previously (Sergerie et al., 2000) . We used flow cytometry to detect TUNEL staining of sperm from patients with sperm concentration >5 3 10 6 /ml, which has been shown to be a feasible and sensitive way to detect DNA fragmentation (Muratori et al., 2008) . TUNEL labeling was carried out using a Cell Death Detection kit (APO-DIRECT kit; BD Biosciences PharMingen), according to the manufacturer's instructions. Briefly, semen samples, frozen at À70°C, were thawed in a 37°C water bath and immediately diluted with buffer (0.15 M NaCl, 0.01 M Tris, 0.001 M EDTA, pH 7.4) to obtain a sperm concentration of 1-2 3 10 6 /ml. Washed sperm were resuspended in 2% paraformaldehyde for 30 min at room temperature. After rinsing in PBS, samples were resuspended in permeabilization solution (0.2% Triton X-100, 0.1% sodium citrate) for 10 min on ice. TUNEL reagent (50 ll) was added to each sample. For each batch, a negative control without the addition of terminal deoxynucleotidyl transferase and a positive control treated with DNase I were included, to ensure assay specificity. After incubation for 1 h at 37°C, samples were analyzed immediately by flow cytometry (FACSCalibur; BD Biosciences Pharmingen). Flow during analysis was controlled at~500 spermatozoa/s, and 10,000 cells were analyzed for each sample. The percentage of fluorescein isothiocyanate (FITC)-positive cells (FL1 channel) was determined as the percentage of cells with a fluorescence intensity exceeding the threshold obtained with the negative control (Supplementary fig. 1 ).
benzo(a)pyrene diolepoxide-DNA adducts determination: immunofluorescence staining. benzo(a)pyrene diolepoxide (BPDE)-DNA adducts were measured by an indirect immunofluorescence method using BPDE-DNA (5D11) monoclonal antibody (sc-52625; Santa Cruz) with FITC-conjugated secondary antibody. The intensity of FITC fluorescence was then detected by the FACSCalibur flow cytometer (BD Biosciences Pharmingen). In brief, washed sperms were resuspended in 2% paraformaldehyde for 30 min at room temperature. After washing with PBS, samples were resuspended in permeabilization solution (0.2% Triton X-100, 0.1% sodium citrate) for 10 min on ice. Samples were washed twice with 13 PBS, treated with 100 lg/ml RNase at 37°C for 1 h, and then with proteinase K (10 lg/ml at room temperature) for 10 min. To denature the DNA, samples were incubated with 4N HCl for 10 min followed by 50mM Tris-base for 5 min at room temperature. After blocking with 5% normal goat serum in Tris buffer (45 min at 37°C), samples were then incubated with mouse monoclonal antibody raised against BPDE-I-G (dilution 1:50 in PBS; overnight at 4°C). After washing with PBS, samples were incubated with FITC-conjugated goat anti-mouse IgG (dilution 1:200 in PBS) at 37°C for 45 min. Samples were washed with PBS and then analyzed immediately by flow cytometry. We analyzed 10,000 individual sperm per sample for FITC fluorescence emission. Mean fluorescence intensity was calculated on a logarithmic scale (Supplementary fig. 2 ). For each batch, a negative control with normal mouse IgG instead of the 5D11 antibody was included.
Statistical analyses. The statistical analyses were performed with the Statistical Analysis System (version 9.1.3, SAS Institute, Cary, NC). Multivariate logistic regression analysis was performed to obtain adjusted odds ratio (OR) for risk of male infertility and their 95% confidence interval (CI). Some of the outcome variables, for example sperm concentration, sperm DNA fragmentation, and BPDE-DNA adducts, had somewhat skewed distributions (checked by skewness-kurtosis tests), and these variables were transformed using the natural logarithm. Multiple linear regression was used to examine the differences of sperm DNA fragmentation and semen quality among AHR genotypes. Bonferroni method was considered to adjust multiplicity of the type 1 error. p Values were two-sided, with p 0.05/18 (p 0.0027) considered as the threshold of significance.
RESULTS

Subject Characteristics
The frequency distributions of selected characteristics of the case and control subjects were presented in Table 1 . There were no significant differences in the age distribution between the cases and controls, suggesting that our frequency matching on age was satisfactory. As expected, there was a marginally significant difference between cases and controls with respect to the smoking status (p ¼ 0.046). Among smokers, cases also reported greater cigarette consumption than controls, as assessed by the mean number of pack-years (p ¼ 0.019).
Allelic Frequencies and Genotype Distributions of AHR Polymorphisms
Six SNPs were finally identified as tagSNPs and the mean r 2 between tagSNPs, and their covered SNPs was 0.966. The position and minor allele frequency of these SNPs among Chinese in the HapMap database were presented in Table 2 . All SNPs were in Hardy-Weinberg equilibrium among the controls. Among these SNPs, the rs2066853 G > A is a nonsynonymous polymorphism that results in Arg to Lys amino acid change. The genotype distributions of the six tagSNPs of AHR in the cases and the controls were shown in Table 3 . In the singlelocus analysis, the rs2158041 genotype frequencies were significantly different between the cases and the controls (p ¼ 6.0 3 10 À6 ). However, as to the other polymorphisms, no significant differences were detected between cases and controls. Multivariate logistic regression analyses revealed that only rs2158041 showed a significant association with male infertility risk (adjusted OR ¼ 1.53, 95% CI ¼ 1.21-1.93 under (Table 3) .
Association between AHR Polymorphisms and Semen Quality
Of the 580 patients, 420 semen samples were available. The sperm concentration, sperm DNA fragmentation, and sperm BPDE-DNA adducts levels were evaluated in different genotype groups of patients (Table 4) . Because the three variables were not normally distributed, natural logarithmic transformation was used to convert them to normal distribution for all statistical procedures. According to the statistical threshold of p 0.0027, only rs2158041 showed a significant association with sperm concentration. Compared with the rs2158041 GG common homozygote, rs2158041 A allele carriers showed significantly lower sperm concentration (mean ± SD, 4.07 ± 0.83, 3.70 ± 0.90, and 3.66 ± 0.79 for GG, GA, and AA, respectively; p 0.001). In addition, a gradual increase of sperm DNA fragmentation and sperm BPDE-DNA adducts was found among the three rs2158041 subgroups, but the differences were not statistically significant (p ! 0.004) (Fig. 1) .
DISCUSSION
Since the discovery of the AHR, studies have determined that it binds numerous xenobiotics and naturally occurring exogenous biological compounds (Billiard et al., 2006; Perdew, 2008) . The binding of xenobiotics and other compounds to the AHR initiates a cascade of events, including gene transcriptions that often lead to toxicity. Because of the wide distribution of AHR pathway proteins in human testicular tissues, we speculated that abnormalities in AHR action could contribute to male factor infertility. In the current study, we asked two questions: (1) whether AHR gene polymorphisms are associated with increased risk of male factor infertility and (2) whether polymorphisms in AHR result in altered sperm function and thereby increase the risk of male infertility.
To our knowledge, our study is the first comprehensive candidate gene study to systematically tag all the known common variants in the AHR gene and to test their associations with male infertility. Herein, we identified a potential contribution of rs2158041 polymorphisms to male infertility risk. In addition, analysis using multivariate linear regression revealed a statistically significant association between rs2158041 variants and altered semen quality. Intriguingly, our findings were consistent with the results from a recent study in cancer. Chen et al. (2009) reported that the rs2158041 heterozygous genotype was associated with a significantly increased risk of lung cancer as compared with the common genotype (adjusted OR ¼ 1.53, 95% CI 1.17-1.99) in a Chinese case-control study of 500 cases and 517 controls. This indicates that diseases may share some fraction of genetic factors. These results could equally indicate that AHR variants might modify the dioxin-induced toxicity effects.
The molecular mechanism by which the AHR gene polymorphisms associated with the phenotypic changes remains unclear. The rs2158041 site is intronic and not located within any conserved region of the AHR gene and thus is unlikely to have any functional effect. However, intronic SNPs are sometimes able to produce alternative splicing (Hirose et al., 2008) or it might be in LD with other causal loci or genes. The exact location and biological functions of the real causal SNPs in AHR are of great interest and warrant further investigation.
One of the nonsignificant SNP (rs2066853, Arg554Lys) in our study is a particularly good candidate because it encodes a nonsynonymous amino acid change. Previous study observes that the AHR-R554K variant displays an increased ability to induce the transcription of CYP1A1 activity in lymphocytes compared with common genotype after induction with 3-methylcholanthrene (Smart and Daly, 2000) . However, conflicting evidence also exists. Some studies show that the R554K change does not alter the ability of AHR to regulate CYP1A1-or CYP1B1-driven transcription (Celius and Matthews, 2010; Koyano et al., 2005; Wong et al., 2001) . So the conflicting evidence suggests that the effect of the AHR-R554K variant is controversial and requires further study.
In summary, we identified a possible contribution of AHR rs2158041 to the significantly increased risk of male infertility. The minor allele of rs2158041 was associated with reduced sperm concentration. These novel findings might be helpful in improving the understanding of the role of genetic variation in susceptibility to male infertility. Further studies with a larger sample size or different ethnic populations are required to elucidate the exact effects of these genetic polymorphisms on the risk of male infertility.
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